Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-062074 Size:6 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-033945 Size:7 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-22-126074 Act: 34 Size:237 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034121 Size:6 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001701541-22-000037 Act: 34 Size:5 MB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) EFFECT Notice of Effectiveness Accession Number: 9999999995-22-003381 Act: 33 Size:1 KB 网页链接
美股滚雪球：
Immix Biopharma(IMMX) 表示，已经成立了一家名为Nexcella的全资子公司，已向Nexcella授权bcma靶向的下一代CAR-T疗法NXC-201(原HBI0101)，以开发NXC-201并可能实现商业化。
IMMX表示，在20例复发/难治性多发性骨髓瘤患者的1b期试验中，该药物显示出约85%的总缓解率(ORR)和71%的完全缓解/严格完全缓解(CR/sCR)。NXC-201在4例复发/难治性AL淀粉样变患者中也产生了100%的ORR和100%的器官反应率。
Immix指出，Nexcella的成立预计对其财务状况的影响最小，因为Nexcella预计将是一家独立融资的公司。
美国多家上市公司分拆药物设立子公司，此前已有Black Diamond(BDTX) 、Crinetics制药(CRNX)
Black Diamond(BDTX)：
Black Diamond(BDTX) S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-22-284590 Act: 33 Size:597 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012796 Size:5 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012795 Size:5 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001104659-22-128050 Act: 34 Size:226 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001701541-22-000034 Act: 34 Size:292 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012966 Size:7 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034543 Size:7 KB 网页链接
Black Diamond(BDTX)：
Black Diamond(BDTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012797 Size:5 KB 网页链接
